Your browser doesn't support javascript.
loading
TLR4 blockade using TAK-242 suppresses ovarian and breast cancer cells invasion through the inhibition of extracellular matrix degradation and epithelial-mesenchymal transition.
Zandi, Zahra; Kashani, Bahareh; Poursani, Ensieh M; Bashash, Davood; Kabuli, Majid; Momeny, Majid; Mousavi-Pak, Seyedeh H; Sheikhsaran, Fatemeh; Alimoghaddam, Kamran; Mousavi, Seyed A; Ghaffari, Seyed H.
Afiliación
  • Zandi Z; Hematology, Oncology and Stem Cell Transplantation Research Center, Shariati Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran; Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Kashani B; Hematology, Oncology and Stem Cell Transplantation Research Center, Shariati Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran; Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Poursani EM; Hematology, Oncology and Stem Cell Transplantation Research Center, Shariati Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Bashash D; Department of Hematology and Blood Banking, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Kabuli M; Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Momeny M; Turku Centre for Biotechnology, University of Turku and Åbo Akademi University, Turku, Finland.
  • Mousavi-Pak SH; Hematology, Oncology and Stem Cell Transplantation Research Center, Shariati Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Sheikhsaran F; Hematology, Oncology and Stem Cell Transplantation Research Center, Shariati Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Alimoghaddam K; Hematology, Oncology and Stem Cell Transplantation Research Center, Shariati Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Mousavi SA; Hematology, Oncology and Stem Cell Transplantation Research Center, Shariati Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Ghaffari SH; Hematology, Oncology and Stem Cell Transplantation Research Center, Shariati Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: shghaffari200@yahoo.com.
Eur J Pharmacol ; 853: 256-263, 2019 Jun 15.
Article en En | MEDLINE | ID: mdl-30930249
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Sulfonamidas / Neoplasias de la Mama / Receptor Toll-Like 4 / Matriz Extracelular / Transición Epitelial-Mesenquimal Límite: Female / Humans Idioma: En Revista: Eur J Pharmacol Año: 2019 Tipo del documento: Article País de afiliación: Irán
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Sulfonamidas / Neoplasias de la Mama / Receptor Toll-Like 4 / Matriz Extracelular / Transición Epitelial-Mesenquimal Límite: Female / Humans Idioma: En Revista: Eur J Pharmacol Año: 2019 Tipo del documento: Article País de afiliación: Irán